Revolution Medicines, Inc. (RVMD) Stock Analysis — Probabli.AI
AI-powered analysis for RVMD (Revolution Medicines, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. Latest AI outlook: Bullish.
Last price: $144.19 · Market cap: $31.8B · AI outlook: Bullish
Revolution Medicines appears to be in a strong position within the biotech sector, supported by a promising product pipeline, consensus bullish views, and positive clinical trial outcomes. While there are risks from competition, high cash burn, and equity issuance, the long-term growth story justifies a bullish stance.
Probabilistic 1-Year Outlook
- Bull 60% · Neutral 30% · Bear 10%
- 1-year price estimates — P10: $125 / P50: $175 / P90: $210
- The company's recent progress in clinical trials and expansion in the oncology market is promising. Analysts are overwhelmingly positive about its short-term prospects, reflected by a strong buy consensus. However,…
5-Year Outlook
- Bull 75% · Neutral 20% · Bear 5%
- 5-year price estimates — P10: $140 / P50: $300 / P90: $500
SWOT Highlights
- Strength: Strong research and development pipeline
- Strength: Innovative oncology treatments
- Risk: Negative recent earnings surprises
- Risk: Volatility in stock performance
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
21 Wall Street analysts rate RVMD a STRONG BUY with a mean price target of $182.78.
Last analyzed · Model: gpt-4o. How this forecast works · Accuracy & validation.
RVMD forecast details · RVMD sentiment details · RVMD insider activity
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.